Literature DB >> 17662717

Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Dustin J Donnelly1, Phillip G Popovich.   

Abstract

Trauma to the central nervous system (CNS) triggers intraparenchymal inflammation and activation of systemic immunity with the capacity to exacerbate neuropathology and stimulate mechanisms of tissue repair. Despite our incomplete understanding of the mechanisms that control these divergent functions, immune-based therapies are becoming a therapeutic focus. This review will address the complexities and controversies of post-traumatic neuroinflammation, particularly in spinal cord. In addition, current therapies designed to target neuroinflammatory cascades will be discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17662717      PMCID: PMC2692462          DOI: 10.1016/j.expneurol.2007.06.009

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  188 in total

1.  A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord.

Authors:  D W Huang; L McKerracher; P E Braun; S David
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system.

Authors:  Iftach Shaked; Ziv Porat; Roman Gersner; Jonathan Kipnis; Michal Schwartz
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

3.  Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury.

Authors:  R D Azbill; X Mu; A J Bruce-Keller; M P Mattson; J E Springer
Journal:  Brain Res       Date:  1997-08-15       Impact factor: 3.252

4.  Matrix metalloproteinases degrade myelin basic protein.

Authors:  S Chandler; R Coates; A Gearing; J Lury; G Wells; E Bone
Journal:  Neurosci Lett       Date:  1995-12-15       Impact factor: 3.046

Review 5.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.

Authors:  E N Benveniste
Journal:  J Mol Med (Berl)       Date:  1997-03       Impact factor: 4.599

6.  Pulsed subcutaneous electrical stimulation in spinal cord injury: preliminary results.

Authors:  W Ellis
Journal:  Bioelectromagnetics       Date:  1987       Impact factor: 2.010

7.  T cell-mediated neuroprotection involves antithrombin activity.

Authors:  I Friedmann; E Hauben; E Yoles; L Kardash; M Schwartz
Journal:  J Neuroimmunol       Date:  2001-12-03       Impact factor: 3.478

Review 8.  Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.

Authors:  Michal Schwartz; Jonathan Kipnis
Journal:  Neuroscientist       Date:  2002-10       Impact factor: 7.519

9.  Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury.

Authors:  W Xu; L Chi; R Xu; Y Ke; C Luo; J Cai; M Qiu; D Gozal; R Liu
Journal:  Spinal Cord       Date:  2005-04       Impact factor: 2.772

10.  Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function.

Authors:  S Elkabes; E M DiCicco-Bloom; I B Black
Journal:  J Neurosci       Date:  1996-04-15       Impact factor: 6.167

View more
  359 in total

Review 1.  Biomaterial Approaches to Modulate Reactive Astroglial Response.

Authors:  Jonathan M Zuidema; Ryan J Gilbert; Manoj K Gottipati
Journal:  Cells Tissues Organs       Date:  2018-12-05       Impact factor: 2.481

2.  IT delivery of ChABC modulates NG2 and promotes GAP-43 axonal regrowth after spinal cord injury.

Authors:  I Novotna; L Slovinska; I Vanicky; M Cizek; J Radonak; D Cizkova
Journal:  Cell Mol Neurobiol       Date:  2011-06-01       Impact factor: 5.046

3.  The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice.

Authors:  Akshata Almad; A Todd Lash; Ping Wei; Amy E Lovett-Racke; Dana M McTigue
Journal:  Exp Neurol       Date:  2011-09-21       Impact factor: 5.330

4.  The relationship between localized subarachnoid inflammation and parenchymal pathophysiology after spinal cord injury.

Authors:  James W Austin; Mehdi Afshar; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2012-07-01       Impact factor: 5.269

5.  Overcoming endogenous constraints on neuronal regeneration.

Authors:  Nassir Mokarram; Ravi V Bellamkonda
Journal:  IEEE Trans Biomed Eng       Date:  2010-12-30       Impact factor: 4.538

6.  Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage.

Authors:  Jonghyuck Park; Lingxing Zheng; Andrew Marquis; Michael Walls; Brad Duerstock; Amber Pond; Sasha Vega-Alvarez; He Wang; Zheng Ouyang; Riyi Shi
Journal:  J Neurochem       Date:  2013-12-15       Impact factor: 5.372

Review 7.  Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair.

Authors:  Inés Maldonado-Lasunción; Joost Verhaagen; Martin Oudega
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 8.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

9.  A Neurosphere Assay to Evaluate Endogenous Neural Stem Cell Activation in a Mouse Model of Minimal Spinal Cord Injury.

Authors:  Nishanth Lakshman; Wenjun Xu; Cindi M Morshead
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

10.  Fibronectin Matrix Assembly after Spinal Cord Injury.

Authors:  Yunjiao Zhu; Cynthia Soderblom; Michelle Trojanowsky; Do-Hun Lee; Jae K Lee
Journal:  J Neurotrauma       Date:  2015-03-09       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.